Biosimilar medicines: Information for General Practitioners.

BIOSIMILAR MEDICINES: INFORMATION FOR GENERAL PRACTITIONERS

Learning outcomes

This activity addresses the following learning outcomes using a combination of reading and active listening to video content.

Upon completion of this activity, participants will be able to:

EXPERTISE    
Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system.
Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines.

PATIENT CARE    
Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product.
Manage patient concerns and queries surrounding biosimilar medicines.

PRACTICE    
Define the criteria that must be met in order to substitute a PBS-subsidised reference biological for a biosimilar medicine.